Direct cystatin C inhibition of tau aggregation

Mechanistic description

Cystatin C binds tau through its cystatin-like domain, sequestering monomeric tau and preventing β-sheet aggregation. This hypothesis has the weakest mechanistic foundation: cystatin C is secreted (extracellular) while tau is predominantly intracellular. The 2005 Co-IP has not been independently replicated in 20+ years. At physiologically relevant concentrations (10-50 nM CSF), any inhibitory effect may be negligible.

Mechanism / pathway

CST3/MAPT interaction
→
neurodegeneration

Evidence for (7)

Cystatin C co-immunoprecipitates with tau in human brain tissue (unreplicated)

PMID:16253072
CST3 polymorphisms associate with differential AD risk in some meta-analyses

PMID:NA
Biochemical analyses of cystatin-C dimers and cathepsin-B reveals a trypsin-driven feedback mechanism in acute pancreatitis.

PMID:39962054 2025 Nat Commun
Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration By release of loop anchoring through mutation of his110.

PMID:11150500 2000 FEBS Lett
Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases.

PMID:7890620 1995 J Biol Chem
Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.

PMID:8471031 1993 Biochem J
Structural basis for different inhibitory specificities of human cystatins C and D.

PMID:9521728 1998 Biochemistry

Evidence against (3)

Localization paradox: extracellular cystatin C vs intracellular tau

PMID:NA
Co-IP not independently replicated in 20+ years

PMID:NA
Species conservation mismatch suggests species-specific artifact

PMID:NA

Evidence matrix

7 supporting 3 contradicting

70% supporting

Supporting

Cystatin C co-immunoprecipitates with tau in human brain tissue (unreplicated) PMID:16253072
CST3 polymorphisms associate with differential AD risk in some meta-analyses PMID:NA
Biochemical analyses of cystatin-C dimers and cathepsin-B reveals a trypsin-driven feedback mechanism in acute pancreatitis. PMID:39962054 · 2025 · Nat Commun
Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration By release of loop anchoring through mutation of his110. PMID:11150500 · 2000 · FEBS Lett
Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases. PMID:7890620 · 1995 · J Biol Chem
Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition. PMID:8471031 · 1993 · Biochem J
Structural basis for different inhibitory specificities of human cystatins C and D. PMID:9521728 · 1998 · Biochemistry

Contradicting

Localization paradox: extracellular cystatin C vs intracellular tau PMID:NA
Co-IP not independently replicated in 20+ years PMID:NA
Species conservation mismatch suggests species-specific artifact PMID:NA

Cite this hypothesis

Citation

etl-backfill (2026). Direct cystatin C inhibition of tau aggregation. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-da6c36b942

BibTeX

@misc{scidex_hypothesis_hda6c36b,
  title        = {Direct cystatin C inhibition of tau aggregation},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-da6c36b942},
  note         = {SciDEX artifact hypothesis:h-da6c36b942}
}